Impact of particle elasticity on particle-based drug delivery systems

Advanced Drug Delivery Reviews

Volumn 108, Issue , 2017, Pages 51-67

  Anselmo, Aaron C ^a   Mitragotri, Samir ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b University of California   (United States)

Author keywords

Circulation; Drug delivery; Elasticity; Endocytosis; Flexibility; Nanoparticles; Rigidity; Targeting

Indexed keywords

BOILER CIRCULATION; CARDIOVASCULAR SYSTEM; DRUG DELIVERY; MOLECULAR BIOLOGY; NANOPARTICLES; RIGIDITY; TISSUE;

CELLULAR INTERNALIZATION; COMPLEX RELATIONSHIPS; DRUG DELIVERY PROCESS; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; FLEXIBILITY; SPECIFIC INTERACTION; TARGETING;

ELASTICITY;

NANOPARTICLE;

BIODEGRADABILITY; CANCER CELL; CELL INTERACTION; CHEMICAL INTERACTION; CIRCULATION; DRUG DELIVERY SYSTEM; ELASTICITY; ENDOTHELIUM CELL; HYDROGEL; IMMUNOCOMPETENT CELL; INTERNALIZATION; MOLECULAR DYNAMICS; NONHUMAN; PHYSICAL PARAMETERS; REVIEW; RIGIDITY; SHEAR STRENGTH; TRANSCYTOSIS; YOUNG MODULUS; ANIMAL; HUMAN; PARTICLE SIZE;

ANIMALS; DRUG DELIVERY SYSTEMS; ELASTICITY; HUMANS; PARTICLE SIZE;

EID: 84955607551     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2016.01.007     Document Type: Review

References (108)

1. [1] Monopoli, M.P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., Dawson, K.A., Physical–chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 133 (2011), 2525–2534.
2. [2] Veiseh, O., Gunn, J.W., Zhang, M., Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev. 62 (2010), 284–304.
3. [3] Albanese, A., Tang, P.S., Chan, W.C., The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 14 (2012), 1–16.
4. [4] Wang, A.Z., Langer, R., Farokhzad, O.C., Nanoparticle delivery of cancer drugs. Annu. Rev. Med. 63 (2012), 185–198.
5. [5] Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R., Langer, R., Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2 (2007), 751–760.
6. [6] Moghimi, S.M., Hunter, A.C., Murray, J.C., Nanomedicine: current status and future prospects. FASEB J. 19 (2005), 311–330.
7. [7] Moghimi, S.M., Hunter, A.C., Murray, J.C., Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53 (2001), 283–318.
8. [8] Brannon-Peppas, L., Blanchette, J.O., Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 64 (2012), 206–212.
9. [9] Davis, M.E., Shin, D.M., Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7 (2008), 771–782.
10. [10] Petros, R.A., DeSimone, J.M., Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 9 (2010), 615–627.
11. [11] Decuzzi, P., Godin, B., Tanaka, T., Lee, S.-Y., Chiappini, C., Liu, X., Ferrari, M., Size and shape effects in the biodistribution of intravascularly injected particles. J. Control. Release 141 (2010), 320–327.
12. [12] Champion, J.A., Katare, Y.K., Mitragotri, S., Particle shape: a new design parameter for micro-and nanoscale drug delivery carriers. J. Control. Release 121 (2007), 3–9.
13. [13] Mitragotri, S., In drug delivery, shape does matter. Pharm. Res. 26 (2009), 232–234.
14. [14] Schaeublin, N.M., Braydich-Stolle, L.K., Schrand, A.M., Miller, J.M., Hutchison, J., Schlager, J.J., Hussain, S.M., Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale 3 (2011), 410–420.
15. [15] El Badawy, A.M., Silva, R.G., Morris, B., Scheckel, K.G., Suidan, M.T., Tolaymat, T.M., Surface charge-dependent toxicity of silver nanoparticles. Environ. Sci. Technol. 45 (2010), 283–287.
16. [16] Yoo, J.-W., Chambers, E., Mitragotri, S., Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Curr. Pharm. Des. 16 (2010), 2298–2307.
17. [17] Owens, D.E. III, Peppas, N.A., Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307 (2006), 93–102.
18. [18] Champion, J.A., Katare, Y.K., Mitragotri, S., Making polymeric micro- and nanoparticles of complex shapes. Proc. Natl. Acad. Sci. 104 (2007), 11901–11904.
19. [19] Perry, J.L., Reuter, K.G., Kai, M.P., Herlihy, K.P., Jones, S.W., Luft, J.C., Napier, M., Bear, J.E., DeSimone, J.M., PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett. 12 (2012), 5304–5310.
20. [20] Merkel, T.J., Jones, S.W., Herlihy, K.P., Kersey, F.R., Shields, A.R., Napier, M., Luft, J.C., Wu, H., Zamboni, W.C., Wang, A.Z., Bear, J.E., DeSimone, J.M., Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 586–591.
21. [21] Best, J.P., Yan, Y., Caruso, F., The role of particle geometry and mechanics in the biological domain. Adv. Healthc. Mater. 1 (2012), 35–47.
22. [22] Sen Gupta, A., Role of Particle Size, Shape, and Stiffness in Design of Intravascular Drug Delivery Systems: Insights from Computations, Experiments, and Nature. 2015, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology.
23. [23] Engler, A.J., Sen, S., Sweeney, H.L., Discher, D.E., Matrix elasticity directs stem cell lineage specification. Cell 126 (2006), 677–689.
24. [24] Rehfeldt, F., Engler, A.J., Eckhardt, A., Ahmed, F., Discher, D.E., Cell responses to the mechanochemical microenvironment—implications for regenerative medicine and drug delivery. Adv. Drug Deliv. Rev. 59 (2007), 1329–1339.
25. [25] Kloxin, A.M., Benton, J.A., Anseth, K.S., In situ elasticity modulation with dynamic substrates to direct cell phenotype. Biomaterials 31 (2010), 1–8.
26. [26] Discher, D.E., Mooney, D.J., Zandstra, P.W., Growth factors, matrices, and forces combine and control stem cells. Science 324 (2009), 1673–1677.
27. [27] Discher, D.E., Janmey, P., Wang, Y.-l., Tissue cells feel and respond to the stiffness of their substrate. Science 310 (2005), 1139–1143.
28. [28] Becker, A.L., Johnston, A.P., Caruso, F., Layer-by-layer-assembled capsules and films for therapeutic delivery. Small 6 (2010), 1836–1852.
29. [29] Zhang, L., Feng, Q., Wang, J., Zhang, S., Ding, B., Wei, Y., Dong, M., Ryu, J.-Y., Yoon, T.-Y., Shi, X., Microfluidic synthesis of hybrid nanoparticles with controlled lipid layers: understanding flexibility-regulated cell–nanoparticle interaction. ACS Nano 9 (2015), 9912–9921.
30. [30] Sun, J., Zhang, L., Wang, J., Feng, Q., Liu, D., Yin, Q., Xu, D., Wei, Y., Ding, B., Shi, X., Jiang, X., Tunable rigidity of (polymeric core)–(lipid shell) nanoparticles for regulated cellular uptake. Adv. Mater. 27 (2015), 1402–1407.
31. [31] Müllner, M., Dodds, S.J., Nguyen, T.-H., Senyschyn, D., Porter, C.J., Boyd, B.J., Caruso, F., Size and rigidity of cylindrical polymer brushes dictate long circulating properties in vivo. ACS Nano 9 (2015), 1294–1304.
32. [32] Peppas, N.A., Hilt, J.Z., Khademhosseini, A., Langer, R., Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv. Mater. 18 (2006), 1345–1360.
33. [33] Drury, J.L., Mooney, D.J., Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 24 (2003), 4337–4351.
34. [34] Seliktar, D., Designing cell-compatible hydrogels for biomedical applications. Science 336 (2012), 1124–1128.
35. [35] Slaughter, B.V., Khurshid, S.S., Fisher, O.Z., Khademhosseini, A., Peppas, N.A., Hydrogels in regenerative medicine. Adv. Mater. 21 (2009), 3307–3329.
36. [36] Anseth, K.S., Bowman, C.N., Brannon-Peppas, L., Mechanical properties of hydrogels and their experimental determination. Biomaterials 17 (1996), 1647–1657.
37. [37] Hoare, T.R., Kohane, D.S., Hydrogels in drug delivery: progress and challenges. Polymer 49 (2008), 1993–2007.
38. [38] Zhang, L., Cao, Z., Li, Y., Ella-Menye, J.R., Bai, T., Jiang, S., Softer zwitterionic nanogels for longer circulation and lower splenic accumulation. ACS Nano 6 (2012), 6681–6686.
39. [39] Banquy, X., Suarez, F., Argaw, A., Rabanel, J.-M., Grutter, P., Bouchard, J.-F., Hildgen, P., Giasson, S., Effect of mechanical properties of hydrogel nanoparticles on macrophage cell uptake. Soft Matter 5 (2009), 3984–3991.
40. [40] Liu, W., Zhou, X., Mao, Z., Yu, D., Wang, B., Gao, C., Uptake of hydrogel particles with different stiffness and its influence on HepG2 cell functions. Soft Matter 8 (2012), 9235–9245.
41. [41] Anselmo, A.C., Zhang, M., Kumar, S., Vogus, D.R., Menegatti, S., Helgeson, M.E., Mitragotri, S., Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting. ACS Nano 9 (2015), 3169–3177.
42. [42] Lee, K.Y., Rowley, J.A., Eiselt, P., Moy, E.M., Bouhadir, K.H., Mooney, D.J., Controlling mechanical and swelling properties of alginate hydrogels independently by cross-linker type and cross-linking density. Macromolecules 33 (2000), 4291–4294.
43. [43] Kloxin, A.M., Kloxin, C.J., Bowman, C.N., Anseth, K.S., Mechanical properties of cellularly responsive hydrogels and their experimental determination. Adv. Mater. 22 (2010), 3484–3494.
44. [44] Haghgooie, R., Toner, M., Doyle, P.S., Squishy non-spherical hydrogel microparticles. Macromol. Rapid Commun. 31 (2010), 128–134.
45. [45] Yan, Y., Such, G.K., Johnston, A.P., Lomas, H., Caruso, F., Toward therapeutic delivery with layer-by-layer engineered particles. ACS Nano 5 (2011), 4252–4257.
46. [46] Yan, Y., Björnmalm, M., Caruso, F., Assembly of layer-by-layer particles and their interactions with biological systems. Chem. Mater. 26 (2013), 452–460.
47. [47] Johnston, A.P., Cortez, C., Angelatos, A.S., Caruso, F., Layer-by-layer engineered capsules and their applications. Curr. Opin. Colloid Interface Sci. 11 (2006), 203–209.
48. [48] Poon, Z., Chang, D., Zhao, X., Hammond, P.T., Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia. ACS Nano 5 (2011), 4284–4292.
49. [49] Morton, S.W., Poon, Z., Hammond, P.T., The architecture and biological performance of drug-loaded LbL nanoparticles. Biomaterials 34 (2013), 5328–5335.
50. [50] Deng, Z.J., Morton, S.W., Ben-Akiva, E., Dreaden, E.C., Shopsowitz, K.E., Hammond, P.T., Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment. ACS Nano 7 (2013), 9571–9584.
51. [51] Zan, X., Garapaty, A., Champion, J.A., Engineering polyelectrolyte capsules with independently controlled size and shape. Langmuir 31 (2015), 7601–7608.
52. [52] Zhou, Z., Anselmo, A.C., Mitragotri, S., Synthesis of protein-based, rod-shaped particles from spherical templates using layer-by-layer assembly. Adv. Mater. 25 (2013), 2723–2727.
53. [53] Fery, A., Dubreuil, F., Möhwald, H., Mechanics of artificial microcapsules. New J. Phys., 6, 2004, 18.
54. [54] Bédard, M.F., Munoz-Javier, A., Mueller, R., Del Pino, P., Fery, A., Parak, W.J., Skirtach, A.G., Sukhorukov, G.B., On the mechanical stability of polymeric microcontainers functionalized with nanoparticles. Soft Matter 5 (2009), 148–155.
55. [55] Dubreuil, F., Shchukin, D.G., Sukhorukov, G.B., Fery, A., Polyelectrolyte capsules modified with YF3 nanoparticles: an AFM study. Macromol. Rapid Commun. 25 (2004), 1078–1081.
56. [56] Gao, C., Leporatti, S., Moya, S., Donath, E., Möhwald, H., Stability and mechanical properties of polyelectrolyte capsules obtained by stepwise assembly of poly (styrenesulfonate sodium salt) and poly (diallyldimethyl ammonium) chloride onto melamine resin particles. Langmuir 17 (2001), 3491–3495.
57. [57] Gao, C., Donath, E., Moya, S., Dudnik, V., Möhwald, H., Elasticity of hollow polyelectrolyte capsules prepared by the layer-by-layer technique. Eur. Phys. J. E 5 (2001), 21–27.
58. [58] Hartmann, R., Weidenbach, M., Neubauer, M., Fery, A., Parak, W.J., Stiffness-dependent in vitro uptake and lysosomal acidification of colloidal particles. Angew. Chem. Int. Ed. 54 (2015), 1365–1368.
59. [59] Sun, H., Wong, E.H., Yan, Y., Cui, J., Dai, Q., Guo, J., Qiao, G.G., Caruso, F., The role of capsule stiffness on cellular processing. Chem. Sci. 6 (2015), 3505–3514.
60. [60] Dubreuil, F., Elsner, N., Fery, A., Elastic properties of polyelectrolyte capsules studied by atomic-force microscopy and RICM. Eur. Phys. J. E 12 (2003), 215–221.
61. [61] Cui, J., Björnmalm, M., Liang, K., Xu, C., Best, J.P., Zhang, X., Caruso, F., Super-soft hydrogel particles with tunable elasticity in a microfluidic blood capillary model. Adv. Mater. 26 (2014), 7295–7299.
62. [62] Cui, J., De Rose, R., Best, J.P., Johnston, A.P., Alcantara, S., Liang, K., Such, G.K., Kent, S.J., Caruso, F., Mechanically tunable, self-adjuvanting nanoengineered polypeptide particles. Adv. Mater. 25 (2013), 3468–3472.
63. [63] Alexander, J.F., Kozlovskaya, V., Chen, J., Kuncewicz, T., Kharlampieva, E., Godin, B., Cubical Shape Enhances the Interaction of Layer-by-layer Polymeric Particles with Breast Cancer Cells, Advanced Healthcare Materials. 2015.
64. [64] Mueller, R., Köhler, K., Weinkamer, R., Sukhorukov, G., Fery, A., Melting of PDADMAC/PSS capsules investigated with AFM force spectroscopy. Macromolecules 38 (2005), 9766–9771.
65. [65] Elsner, N., Kozlovskaya, V., Sukhishvili, S.A., Fery, A., pH-triggered softening of crosslinked hydrogen-bonded capsules. Soft Matter 2 (2006), 966–972.
66. [66] Allen, T.M., Cullis, P.R., Drug delivery systems: entering the mainstream. Science 303 (2004), 1818–1822.
67. [67] Yoo, J.W., Irvine, D.J., Discher, D.E., Mitragotri, S., Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat. Rev. Drug Discov. 10 (2011), 521–535.
68. [68] Anselmo, A.C., Mitragotri, S., Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles. J. Control. Release 190 (2014), 531–541.
69. [69] Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V., Langer, R., Biodegradable long-circulating polymeric nanospheres. Science 263 (1994), 1600–1603.
70. [70] Champion, J., Mitragotri, S., Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. 103 (2006), 4930–4934.
71. [71] Anselmo, A.C., Gilbert, J.B., Kumar, S., Gupta, V., Cohen, R.E., Rubner, M.F., Mitragotri, S., Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation. J. Control. Release 199 (2015), 29–36.
72. [72] Sosale, N.G., Rouhiparkouhi, T., Bradshaw, A.M., Dimova, R., Lipowsky, R., Discher, D.E., Cell rigidity and shape override CD47's ‘self'’-signaling in phagocytosis by hyperactivating myosin-II. Blood 125 (2015), 542–552.
73. [73] Beningo, K.A., Wang, Y.-l., Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J. Cell Sci. 115 (2002), 849–856.
74. [74] Key, J., Palange, A.L., Gentile, F., Ayral, S., Stigliano, C., Di Mascolo, D., De Rosa, E., Cho, M., Lee, Y., Singh, J., Decuzzi, P., Soft discoidal polymeric nanoconstructs resist macrophage uptake and enhance vascular targeting in tumors. ACS Nano 9 (2015), 11628–11641.
75. [75] Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., Discher, D.E., Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2 (2007), 249–255.
76. [76] Kolhar, P., Anselmo, A.C., Gupta, V., Pant, K., Prabhakarpandian, B., Ruoslahti, E., Mitragotri, S., Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proc. Natl. Acad. Sci. 110 (2013), 10753–10758.
77. [77] Verma, A., Stellacci, F., Effect of surface properties on nanoparticle–cell interactions. Small 6 (2010), 12–21.
78. [78] Mosqueira, V.C.F., Legrand, P., Gulik, A., Bourdon, O., Gref, R., Labarre, D., Barratt, G., Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. Biomaterials 22 (2001), 2967–2979.
79. [79] Herant, M., Heinrich, V., Dembo, M., Mechanics of neutrophil phagocytosis: behavior of the cortical tension. J. Cell Sci. 118 (2005), 1789–1797.
80. [80] Brigger, I., Dubernet, C., Couvreur, P., Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54 (2002), 631–651.
81. [81] Anselmo, A.C., Mitragotri, S., A review of clinical translation of inorganic nanoparticles. AAPS J. 17 (2015), 1041–1054.
82. [82] Anselmo, A.C., Mitragotri, S., An overview of clinical and commercial impact of drug delivery systems. J. Control. Release 190 (2014), 15–28.
83. [83] Farokhzad, O.C., Cheng, J., Teply, B.A., Sherifi, I., Jon, S., Kantoff, P.W., Richie, J.P., Langer, R., Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. 103 (2006), 6315–6320.
84. [84] Byrne, J.D., Betancourt, T., Brannon-Peppas, L., Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev. 60 (2008), 1615–1626.
85. [85] Marusyk, A., Polyak, K., Tumor heterogeneity: causes and consequences, Biochimica et Biophysica Acta (BBA)—reviews on Cancer., 1805, 2010, 105–117.
86. [86] Longo, D.L., Tumor heterogeneity and personalized medicine. N. Engl. J. Med. 366 (2012), 956–957.
87. [87] Howard, M., Zern, B.J., Anselmo, A.C., Shuvaev, V.V., Mitragotri, S., Muzykantov, V., Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. ACS Nano 8 (2014), 4100–4132.
88. [88] Brenner, J.S., Greineder, C., Shuvaev, V., Muzykantov, V., Endothelial nanomedicine for the treatment of pulmonary disease. Expert Opin. Drug Deliv. 12 (2015), 239–261.
89. [89] Myerson, J.W., Anselmo, A.C., Liu, Y., Mitragotri, S., Eckmann, D.M., Muzykantov, V.R., Non-affinity factors modulating vascular targeting of nano- and microcarriers. Adv. Drug Deliv. Rev. 99 (2016), 97–112.
90. [90] Mitragotri, S., Burke, P.A., Langer, R., Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat. Rev. Drug Discov. 13 (2014), 655–672.
91. [91] Mitragotri, S., Anderson, D.G., Chen, X., Chow, E.K., Ho, D., Kabanov, A.V., Karp, J.M., Kataoka, K., Mirkin, C.A., Petrosko, S.H., Accelerating the translation of nanomaterials in biomedicine. ACS Nano 9 (2015), 6644–6654.
92. [92] Alexis, F., Pridgen, E., Molnar, L.K., Farokhzad, O.C., Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5 (2008), 505–515.
93. [93] Li, S.-D., Huang, L., Pharmacokinetics and biodistribution of nanoparticles. Mol. Pharm. 5 (2008), 496–504.
94. [94] Moghimi, S.M., Hunter, A., Andresen, T., Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu. Rev. Pharmacol. Toxicol. 52 (2012), 481–503.
95. [95] Anselmo, A.C., Modery-Pawlowski, C.L., Menegatti, S., Kumar, S., Vogus, D.R., Tian, L.L., Chen, M., Squires, T.M., Sen Gupta, A., Mitragotri, S., Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries. ACS Nano 8 (2014), 11243–11253.
96. [96] Zhang, S., Gao, H., Bao, G., Physical principles of nanoparticle cellular endocytosis. ACS Nano 9 (2015), 8655–8671.
97. [97] Yi, X., Shi, X., Gao, H., Cellular uptake of elastic nanoparticles. Phys. Rev. Lett., 107, 2011, 098101.
98. [98] Li, Y., Zhang, X., Cao, D., Nanoparticle hardness controls the internalization pathway for drug delivery. Nanoscale 7 (2015), 2758–2769.
99. [99] Yi, X., Gao, H., Phase diagrams and morphological evolution in wrapping of rod-shaped elastic nanoparticles by cell membrane: a two-dimensional study. Phys. Rev. E Stat. Nonlinear Soft Matter Phys., 89, 2014, 062712.
100. [100] Yi, X., Gao, H., Cell membrane wrapping of a spherical thin elastic shell. Soft Matter 11 (2015), 1107–1115.
101. [101] Tang, H., Ye, H., Zhang, H., Zheng, Y., Wrapping of nanoparticles by the cell membrane: the role of interactions between the nanoparticles. Soft Matter 11 (2015), 8674–8683.
102. [102] Lockman, P., Mumper, R., Khan, M., Allen, D., Nanoparticle technology for drug delivery across the blood–brain barrier. Drug Dev. Ind. Pharm. 28 (2002), 1–13.
103. [103] Pardridge, W.M., Blood–brain barrier delivery. Drug Discov. Today 12 (2007), 54–61.
104. [104] Fang, J., Nakamura, H., Maeda, H., The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev. 63 (2011), 136–151.
105. [105] Torchilin, V., Tumor delivery of macromolecular drugs based on the EPR effect. Adv. Drug Deliv. Rev. 63 (2011), 131–135.
106. [106] Sun, H., Björnmalm, M., Cui, J., Wong, E.H., Dai, Y., Dai, Q., Qiao, G.G., Caruso, F., Structure governs the deformability of polymer particles in a microfluidic blood capillary model. ACS Macro Lett. 4 (2015), 1205–1209.
107. [107] Serda, R.E., Gu, J., Bhavane, R.C., Liu, X., Chiappini, C., Decuzzi, P., Ferrari, M., The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials 30 (2009), 2440–2448.
108. [108] Moyano, D.F., Goldsmith, M., Solfiell, D.J., Landesman-Milo, D., Miranda, O.R., Peer, D., Rotello, V.M., Nanoparticle hydrophobicity dictates immune response. J. Am. Chem. Soc. 134 (2012), 3965–3967.